Table 1.
List of chemotherapy agents which cause cardiotoxicity
| Serial No | Agent | Cardiotoxic Effect | Management | Ref |
|---|---|---|---|---|
| Anthracyclines and Antitumor Antibiotics | ||||
| 1. | Doxorubicin | LV dysfunction/HF/Arrhythmias | • General-Dexrazoxane | [4,10,19,21,30] |
| • LV dysfunction-D/C agent, ACEI, and β-blocker | ||||
| • HF-D/C agent, ACEI (enalapril), and β-blocker (Carvedilol) | ||||
| • Arrhythmias-antiarrhythmics | ||||
| 2. | Daunorubicin | LV dysfunction/HF/Arrhythmias | • General-Dexrazoxane | [4,10,19,21,30] |
| • LV dysfunction-D/C agent, ACEI, and β-blocker | ||||
| • HF-D/C agent, ACEI (enalapril), and β-blocker (Carvedilol) | ||||
| • Arrhythmias-antiarrhythmics | ||||
| 3. | Mitoxantrone | LV dysfunction/HF/Arrhythmias | • General-Dexrazoxane | [4,10,19,21,30] |
| • LV dysfunction-D/C agent, ACEI, and β-blocker | ||||
| • HF-D/C agent, ACEI (enalapril), and β-blocker (Carvedilol) | ||||
| • Arrhythmias-antiarrhythmics | ||||
| 4. | Epirubicin | LV dysfunction/HF/Arrhythmias | • General-Dexrazoxane | [4,10,19,21,30] |
| • LV dysfunction-D/C agent, ACEI, and β-blocker | ||||
| • HF-D/C agent, ACEI (enalapril), and β-blocker (Carvedilol) | ||||
| • Arrhythmias-antiarrhythmics | ||||
| 5. | Mitoxantrone | Arrhythmia/HF | • Arrhythmias-antiarrhythmics | [25] |
| • HF-D/C agent, ACEI, and β-blocker | ||||
| 6. | Bleomycin | Pericarditis/CAD/Atherosclerosis | • Pericarditis-NSAIDs, colchicine; prednisone if severe | [25,54] |
| • CAD-statin, ADP receptor inhibitor, nitrate, β-blocker | ||||
| • Atherosclerosis-statins | ||||
| 7. | Mitomycin C | HF | • HF-D/C agent, ACEI, and β-blocker | [25] |
| Alkylating agents | ||||
| 1. | Cyclophosphamide | Cardiac Tamponade/Arrhythmias/HF | • Cardiac Tamponade-pericardiocentesis, dobutamine | [10,25,27] |
| • Arrhythmias-antiarrhythmics | ||||
| • HF-D/C agent, ACEI, and β-blocker | ||||
| 2. | Ifosfamide | Similar to Cyclophosphamide | [10,25] | |
| 3. | Bleomycin | Myocardial Ischemia | • Myocardial ischemia-anticoagulation, aspirin, ADP receptor inhibitor | [10,56] |
| 4. | Melphalan | Acute cardiomyopathy | • Acute cardiomyopathy-D/C agent, ACEI, β-blocker, cardiac glycoside | [43] |
| Platinum based agents | ||||
| 1. | Cisplatin | HTN/CAD/Thromboembolic Events/Angina/HF/Arrythmias | • HTN-ACEI and Ca2+ channel blocker (CCB) | [2,10,25,54,56] |
| • CAD-statin, ADP receptor inhibitor, nitrate, β-blocker | ||||
| • Thromboembolic Events-LMWH, edoxaban, or rivaroxaban | ||||
| • HF-D/C agent, ACEI, and β-blocker | ||||
| • Angina-aspirin, ADP receptor inhibitor, nitrate, β-blocker | ||||
| • Arrythmias-antiarrhythmics | ||||
| Antimetabolites | ||||
| 1. | 5-fluorouracil | Angina/MI/Arrhythmias/Cardiomyopathy/HF | • General-D/C agent | [2,25,30,31,35] |
| • Angina-aspirin, ADP receptor inhibitor, nitrate, β-blocker | ||||
| • MI-PCI or IV thrombolytics as per AHA guidelines | ||||
| • Arrhythmia-if acute and pt unstable: cardioversion or defibrillation; Long term treatment with antiarrhythmics | ||||
| • Cardiomyopathy-aspirin, statin, β-blocker | ||||
| • HF-ACEI and β-blocker | ||||
| 2. | Capecitabine | Similar to 5-FU | [2,25,31] | |
| Antimicrotubular Agents | ||||
| 1. | Paclitaxel | Arrhythmia/Heart Block/HF/HTN | • Arrhythmias-antiarrhythmics | [2,10,30,54] |
| • Heart Block-monitoring; potential pacemaker placement | ||||
| • HF-D/C agent, ACEI, and β-blocker | ||||
| • HTN-ACEI and CCB | ||||
| 2. | Docetaxel | Arrhythmia/Heart Block/HF | • Arrhythmias-antiarrhythmics | [2,10,25,30] |
| • Heart Block-monitoring; potential pacemaker placement | ||||
| • HF-D/C agent, ACEI, and β-blocker | ||||
| 3. | Vinblastine | Angina/MI | • Angina-aspirin, ADP receptor inhibitor, nitrate, β-blocker | [10,56] |
| • MI-PCI or IV thrombolytics as per AHA guidelines | ||||